This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Irwin A. Brody; Robert H. Wilkins, MD

Arch Neurol. 1967;17(5):552-553.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE credit for discovering a "new disease" is often given not to the one who describes it first but to the one who describes it when the time is ripe. Thus, Virchow,¹ Schultze,² and others had reported cases of peroneal atrophy previously, but in 1886 medical knowledge had advanced sufficiently to accept this entity as a nosologic addition. The simultaneous publications by Charcot and Marie in France and by Tooth³ in England do not attest to coincidence but to the fact that the medical world was ready to appreciate the finer clinical distinctions existing within the large group of progressive muscular atrophies.

Jean Martin Charcot and his pupil Pierre Marie carefully studied the multitude of infirm and paralytic inmates at the Salpêtrière, an asylum in Paris, and left a scientific discipline where there had been a muddle.⁴ Their description of peroneal atrophy is only one . . . [Full Text PDF of this Article]

Author Affiliations
Durham, NC

From the Division of Neurology and Neurosurgery, Duke University Medical Center, Durham, NC.

Footnotes
Submitted for publication May 31, 1967; accepted July 7.

Reprint requests to Division of Neurology and Neurosurgery, Duke University Medical Center, Durham, NC 27706 (Dr. Wilkins).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?